NASDAQ: CPRX
Catalyst Pharmaceuticals Inc Stock Ownership - Who owns Catalyst Pharmaceuticals?

Insider buying vs selling

Have Catalyst Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Molly HarperDirector2025-12-1215,527$23.20
$360.20kSell
Molly HarperDirector2025-12-126,746$23.06
$155.56kSell
Molly HarperDirector2025-12-124,473$23.73
$106.16kSell
Molly HarperDirector2025-12-1220,000$5.78
$115.60kBuy
Carmen Jeffrey DelChief Commercial Officer2025-11-2610,983$23.33
$256.24kSell
Carmen Jeffrey DelChief Commercial Officer2025-11-2610,983$4.21
$46.24kBuy
Brian ElsberndChief ComplianceLegal Officer2025-11-1240,000$22.70
$908.00kSell
Brian ElsberndChief ComplianceLegal Officer2025-09-08112,475$2.24
$251.94kBuy
Brian ElsberndChief ComplianceLegal Officer2025-09-0830,000$20.30
$609.00kSell
Brian ElsberndChief ComplianceLegal Officer2025-09-0430,000$2.24
$67.20kBuy

1 of 3

CPRX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CPRX insiders and whales buy or sell their stock.

CPRX Shareholders

What type of owners hold Catalyst Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc15.25%18,626,781$424.50MInstitution
Vanguard Group Inc6.90%8,432,247$192.17MInstitution
State Street Corp5.66%6,907,622$157.42MInstitution
Biomarin Pharmaceutical Inc5.46%6,666,667$151.93MInsider
Deerfield Management Company LP4.02%4,911,161$111.93MInstitution
Patrick J. McEnany3.77%4,609,324$105.05MInsider
Hubert E. Md Huckel3.11%3,793,238$86.45MInsider
Fundsmith LLP2.75%3,363,807$76.66MInstitution
American Century Companies Inc2.48%3,025,271$68.95MInstitution
Dimensional Fund Advisors LP2.45%2,996,297$68.29MInstitution

1 of 3

CPRX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CPRX84.18%15.82%Net Selling
TNGX67.46%32.54%Net SellingNet Selling
VRDN77.60%22.40%Net BuyingNet Selling
ARQT77.20%22.80%Net SellingNet Selling
TARS72.94%27.06%Net SellingNet Selling

Catalyst Pharmaceuticals Stock Ownership FAQ

Who owns Catalyst Pharmaceuticals?

Catalyst Pharmaceuticals (NASDAQ: CPRX) is owned by 85.12% institutional shareholders, 15.99% Catalyst Pharmaceuticals insiders, and 0.00% retail investors. Biomarin Pharmaceutical Inc is the largest individual Catalyst Pharmaceuticals shareholder, owning 6.67M shares representing 5.46% of the company. Biomarin Pharmaceutical Inc's Catalyst Pharmaceuticals shares are currently valued at $151.93M.

If you're new to stock investing, here's how to buy Catalyst Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.